Cargando…
Addition of MPS-II to the Recommended Uniform Screening Panel in the United States
Autores principales: | Millington, David S., Ficicioglu, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624303/ https://www.ncbi.nlm.nih.gov/pubmed/36278625 http://dx.doi.org/10.3390/ijns8040055 |
Ejemplares similares
-
The Editor’s Choice for Issue 2, Volume 7
por: Ficicioglu, Can
Publicado: (2021) -
Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021) -
Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities
por: Puckett, Yana, et al.
Publicado: (2021) -
New tools and approaches to newborn screening: ready to open Pandora's box?
por: Ficicioglu, Can
Publicado: (2017) -
Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
por: Ayodele, Olulade, et al.
Publicado: (2022)